Mark Packer, MD, FACS, CPI
Pearls and pitfalls for principal investigators
Pearls and pitfalls for principal investigators
Interested in becoming a principal researcher? Read this first.
Do you have what it takes to be a principal investigator?
Ophthalmologists often approach me about getting involved in clinical research, mostly because they know that I’ve been a principal investigator, medical monitor, or clinical consultant in over 60 trials related to FDA clearances and approvals. Here’s what I tell them.
Mark Packer, MD: Sitting on the DOCK of the bay
The DOCK, of course, is the Demonstration of Ophthalmic Cognitive Knowledge, the final step for me in completing my second round of Maintenance of Certification requirements for the American Board of Ophthalmology (ABO). Taking this exam initiated a period of contemplation regarding where I’ve been and where I’m going.
Directly targeting pathology: A novel approach to treating glaucoma
Rho kinase inhibitors are intriguing in that they work directly on the pathogenic mechanism of abnormally elevated IOP, increased resistance to trabecular outflow.